Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editorial Board196
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer163
Exploiting antifungal immunity in the clinical context95
Differential immune responses behind different celiac disease manifestations83
Cellular stress and macrophage activation70
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity62
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells62
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi61
Pyroptosis modulation by bacterial effector proteins58
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity56
Resolving inflammatory links between myocardial infarction and vascular dementia53
Aging of lymphoid stromal architecture impacts immune responses51
Editorial Board49
Local and Cell-intrinsic complement: The new player in cancer progression47
Microbial metabolites and immunotherapy: Basic rationale and clinical indications45
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges45
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)45
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity43
Immunity to pathogenic fungi in the eye43
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?41
The noncanonical inflammasome-induced pyroptosis and septic shock40
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease38
Pyroptosis and the cellular consequences of gasdermin pores38
Interplay between the complement system and other immune pathways in the tumor microenvironment37
Pyroptosis: A road to next-generation cancer immunotherapy37
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity37
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment34
Western diet influences on microbiome and carcinogenesis34
Immunity to fungi: Editorial overview32
Introduction to the special issue: Neutrophils in the tumor microenvironment32
Cellular and molecular diversity in spondyloarthritis31
The evolving biology of cross-presentation29
The paradox of aging: Aging-related shifts in T cell function and metabolism29
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets28
Neuroimmune interactions between itch neurons and skin microbes28
Adaptive NK cell response to human cytomegalovirus: Facts and open issues27
Autoimmune diabetes and targets for immunomodulation27
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases26
TREM2: A new player in the tumor microenvironment26
Specialized pro-resolving mediators as modulators of immune responses26
Recent developments in C3-targeted complement therapeutics25
Antigen discovery for the development of cancer immunotherapy24
Thymus aging and immune reconstitution, progresses and challenges24
The dual role of neutrophils in cancer23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy23
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination22
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs22
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic22
T cell control of SARS-CoV-2: When, which, and where?22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases22
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Targeting the tissue-complosome for curbing inflammatory disease21
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity21
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy21
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?21
Publisher's note: Welcome Prof. Guido Kroemer20
T cell fate decisions during memory cell generation with aging20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
Better safe than sorry: Naive T-cell dynamics in healthy ageing19
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice19
Editorial Board19
The glycoimmune landscape in health and disease18
The complement system in clinical oncology: Applications, limitations and challenges18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis18
Proteostasis in T cell aging18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells17
Natural killer cell responses to human oncogenic γ-herpesvirus infections17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease17
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy17
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging16
Emerging opportunities for C3 inhibition in the eye16
Cellular and molecular heterogeneity in systemic lupus erythematosus16
Identification of T cell antigens in the 21st century, as difficult as ever16
Harnessing complement biomarkers for precision cancer care16
The gut-enthesis axis and the pathogenesis of Spondyloarthritis15
Global aspects of celiac disease and food allergy15
The multisensory regulation of unconventional T cell homeostasis15
Epigenetic and transcriptional control of gasdermins15
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions15
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]14
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics14
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches14
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation14
A major mechanism for immunomodulation: Dietary fibres and acid metabolites14
Human thymus in health and disease: Recent advances in diagnosis and biology14
Unconventional protein secretion by gasdermin pores14
Siglecs as modulators of macrophage phenotype and function14
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review14
Microbial gasdermins: More than a billion years of pyroptotic-like cell death13
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC13
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond13
Durability of immune responses to SARS-CoV-2 infection and vaccination13
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases13
Systems analysis of innate and adaptive immunity in Long COVID13
Impact of cancer cell-intrinsic features on neutrophil behavior13
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data12
Pyroptosis-induced inflammation and tissue damage12
The role of ILC subsets in cancer12
Integrating immunopeptidome analysis for the design and development of cancer vaccines11
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease11
Reparative inflammation in multiple sclerosis11
Editorial Board11
Regulatory T cells in allergic inflammation10
Complement regulation in tumor immune evasion10
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond10
Galectins and Host–Pathogen Interactions: The roles in viral infections10
The gut-brain vascular axis in neuroinflammation10
Neutrophil metabolism in the cancer context10
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation10
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies10
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions10
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas10
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives9
Systems analysis of human innate immunity in COVID-199
To die or not to die: Gasdermins in intestinal health and disease9
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies9
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences9
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function9
The role of sialoglycans in modulating dendritic cell function and tumour immunity9
The role of neutrophil extracellular traps in cancer progression and metastasis9
Publisher’s Note: A change in leadership9
Editorial Board9
Immunity to fungi in the lung9
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging9
0.046679973602295